- Home
- NVAX vs AG Comparison
NVAX vs AG Comparison
Compare NVAX & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- AG
- Stock Information
- Founded
- NVAX 1987
- AG 1979
- Country
- NVAX United States
- AG Canada
- Employees
- NVAX N/A
- AG N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- AG Precious Metals
- Sector
- NVAX Health Care
- AG Basic Materials
- Exchange
- NVAX Nasdaq
- AG Nasdaq
- Market Cap
- NVAX 2.0B
- AG 2.3B
- IPO Year
- NVAX 1995
- AG N/A
- Fundamental
- Price
- NVAX $8.47
- AG $6.31
- Analyst Decision
- NVAX Buy
- AG Buy
- Analyst Count
- NVAX 6
- AG 2
- Target Price
- NVAX $17.83
- AG $7.50
- AVG Volume (30 Days)
- NVAX 5.8M
- AG 10.8M
- Earning Date
- NVAX 11-12-2024
- AG 11-07-2024
- Dividend Yield
- NVAX N/A
- AG 0.28%
- EPS Growth
- NVAX N/A
- AG N/A
- EPS
- NVAX N/A
- AG N/A
- Revenue
- NVAX $885,193,000.00
- AG $525,212,999.00
- Revenue This Year
- NVAX N/A
- AG N/A
- Revenue Next Year
- NVAX N/A
- AG $26.61
- P/E Ratio
- NVAX N/A
- AG N/A
- Revenue Growth
- NVAX N/A
- AG N/A
- 52 Week Low
- NVAX $3.53
- AG $4.17
- 52 Week High
- NVAX $23.86
- AG $8.44
- Technical
- Relative Strength Index (RSI)
- NVAX 41.69
- AG 42.52
- Support Level
- NVAX $6.81
- AG $6.11
- Resistance Level
- NVAX $10.39
- AG $6.79
- Average True Range (ATR)
- NVAX 0.66
- AG 0.28
- MACD
- NVAX 0.09
- AG -0.05
- Stochastic Oscillator
- NVAX 46.37
- AG 28.15
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
About AG First Majestic Silver Corp. (Canada)
First Majestic Silver Corp is engaged in the production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. It owns three producing mines, in Mexico consisting of the San Dimas Silver/Gold Mine, the Santa Elena Silver/Gold Mine and the La Encantada Silver Mine.